Arena Pharmaceuticals, Inc. Litigation Settlement, Expense
Arena Pharmaceuticals, Inc. reported Litigation Settlement, Expense of $11.97 million for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2020-02-27
- Arena Pharmaceuticals, Inc. litigation settlement, expense for the quarter ending 2017-12-31 was $0.00.
- Arena Pharmaceuticals, Inc. litigation settlement, expense for the quarter ending 2017-09-30 was $11.97M.
- Arena Pharmaceuticals, Inc. litigation settlement, expense for fiscal 2017 was $11.97M.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 9 month | Litigation Settlement, Expense 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $11.97M derived: sum of 2 quarters · filed 2020-02-27 | $11.97M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $11.97M 10-Q · filed 2018-11-08 | $11.97M 10-Q · filed 2018-11-08 |